212 related articles for article (PubMed ID: 25468916)
21. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
Mengelbier LH; Karlsson J; Lindgren D; Valind A; Lilljebjörn H; Jansson C; Bexell D; Braekeveldt N; Ameur A; Jonson T; Kultima HG; Isaksson A; Asmundsson J; Versteeg R; Rissler M; Fioretos T; Sandstedt B; Börjesson A; Backman T; Pal N; Øra I; Mayrhofer M; Gisselsson D
Nat Commun; 2015 Jan; 6():6125. PubMed ID: 25625758
[TBL] [Abstract][Full Text] [Related]
22. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.
Huang S
Prog Biophys Mol Biol; 2012 Sep; 110(1):69-86. PubMed ID: 22579660
[TBL] [Abstract][Full Text] [Related]
23. The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies.
Attili I; Del Re M; Guerini-Rocco E; Crucitta S; Pisapia P; Pepe F; Barberis M; Troncone G; Danesi R; de Marinis F; Malapelle U; Passaro A
Expert Rev Mol Diagn; 2021 Aug; 21(8):757-766. PubMed ID: 34278933
[No Abstract] [Full Text] [Related]
24. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
25. Phylogenetic Quantification of Intratumor Heterogeneity.
Watkins TBK; Schwarz RF
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28710259
[TBL] [Abstract][Full Text] [Related]
26. The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing.
Wood HM; Conway C; Daly C; Chalkley R; Berri S; Senguven B; Stead L; Ross L; Egan P; Chengot P; Graham J; Sethi N; Ong TK; High A; MacLennan K; Rabbitts P
J Pathol; 2015 Nov; 237(3):296-306. PubMed ID: 26096211
[TBL] [Abstract][Full Text] [Related]
27. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
Aleskandarany MA; Vandenberghe ME; Marchiò C; Ellis IO; Sapino A; Rakha EA
Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
[TBL] [Abstract][Full Text] [Related]
28. Evolutionary scalpels for dissecting tumor ecosystems.
Rosenbloom DIS; Camara PG; Chu T; Rabadan R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
[TBL] [Abstract][Full Text] [Related]
29. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
Jiang Y; Qiu Y; Minn AJ; Zhang NR
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
[TBL] [Abstract][Full Text] [Related]
30. Harnessing Tumor Evolution to Circumvent Resistance.
Pogrebniak KL; Curtis C
Trends Genet; 2018 Aug; 34(8):639-651. PubMed ID: 29903534
[TBL] [Abstract][Full Text] [Related]
31. Tumour evolution inferred by single-cell sequencing.
Navin N; Kendall J; Troge J; Andrews P; Rodgers L; McIndoo J; Cook K; Stepansky A; Levy D; Esposito D; Muthuswamy L; Krasnitz A; McCombie WR; Hicks J; Wigler M
Nature; 2011 Apr; 472(7341):90-4. PubMed ID: 21399628
[TBL] [Abstract][Full Text] [Related]
32. The causes of evolvability and their evolution.
Payne JL; Wagner A
Nat Rev Genet; 2019 Jan; 20(1):24-38. PubMed ID: 30385867
[TBL] [Abstract][Full Text] [Related]
33. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
Venesio T; Siravegna G; Bardelli A; Sapino A
Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
[TBL] [Abstract][Full Text] [Related]
34. Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution.
Venkatesan S; Swanton C; Taylor BS; Costello JF
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28289245
[TBL] [Abstract][Full Text] [Related]
35. Recent advances and current issues in single-cell sequencing of tumors.
Sun HJ; Chen J; Ni B; Yang X; Wu YZ
Cancer Lett; 2015 Aug; 365(1):1-10. PubMed ID: 26003306
[TBL] [Abstract][Full Text] [Related]
36. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract][Full Text] [Related]
37. Tumor heterogeneity confounds and illuminates: a case for Darwinian tumor evolution.
Polyak K
Nat Med; 2014 Apr; 20(4):344-6. PubMed ID: 24710378
[No Abstract] [Full Text] [Related]
38. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
[TBL] [Abstract][Full Text] [Related]
39. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
Brychtová V; Valík V; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
[TBL] [Abstract][Full Text] [Related]
40. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
